About
This course provides an objective, data-driven analysis of the acute effects, biological mechanisms, and research findings comparing alcohol and cannabis. Participants will examine the pharmacology of GABA-A and CB1 receptor interactions to understand why physical and cognitive impairments differ between the two substances. The curriculum details findings from federal health agencies and peer-reviewed studies regarding driving safety, cardiovascular impact, and metabolic predictability. By evaluating clinical trials on toxicity, addiction risk, and synergistic effects, this program offers a comprehensive evidence-based framework for professionals in healthcare, safety, and leadership roles.
You can also join this program via the mobile app. Go to the app